The top pharmaceutical companies by R&D expenditure [Yahoo! Finance]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance
the pandemic and the research and development (R&D) focus shifted to other sectors in the drug development space such as the obesity and oncology. Last year, major pharmaceutical companies heavily invested in R&D, with expenditure ranging from around 14% to 50% of their revenues. Some of the emerging R&D trends include a resurgence in investment and pipeline activity with a focus on radiopharmaceuticals and targeted therapies in oncology. In this feature, we analyse publicly available data on how much leading pharma companies have spent on R&D expenditure in 2023. This analysed R&D investments were in the form of strategic acquisitions to expand a company's prowess in a particular area or by in-licensing drug candidates to beef up their pipelines. Merck & Co- $30.5bn Roche- $15.56bn (CHF 14.20bn) Johnson & Johnson- $15.09bn Novartis- $ 11.37bn AstraZeneca- $10.94bn Pfizer- $10.58bn Eli Lilly- $9.31bn Bristol Myers Squibb- $9.21bn AbbVie- $7.68bn Sanofi- $7.18bn
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Global Veterinary Eye Care Market Size, Share & Trends Analysis Report 2024-2030: Collaborative Efforts Advance Early Detection, Laser Therapy Gains Popularity, New Technologies Elevate Care [Yahoo! Finance]Yahoo! Finance
- Cramer says these 10 stocks helped the Dow briefly crack 40,000 [CNBC]CNBC
- Merck (MRK) Crossed Above the 20-Day Moving Average: What That Means for Investors [Yahoo! Finance]Yahoo! Finance
- NMSDC Recognizes 2024 Equity Honors Recipients [Yahoo! Finance]Yahoo! Finance
- XtalPi to Host Inaugural Symposium on the Acceleration of Drug Discovery Through the Use of AI, Automation, and Digitalization [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 4/25/24 - Beat
MRK
Sec Filings
- 5/15/24 - Form 424B5
- 5/15/24 - Form POSASR
- 5/6/24 - Form 144
- MRK's page on the SEC website